DataVXJournal of Nanoparticle ResearchPaper
journal article·2024-07

Drug delivery systems for tissue engineering: exploring novel strategies for enhanced regeneration

Julia Lemos de Oliveira, Maria Eduarda Xavier da Silva, Dachamir Hotza, Claudia Sayer, Ana Paula Serafini Immich

Journal of Nanoparticle Research· Volume 26· Issue 7
Publisher page
Bibliographic record

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

Biomaterials

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · 3D Printing in Biomedical Research · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. MacCord K, Maienschein J (2021) Explaining regeneration: cells and limbs as complex living systems, learning from history. Front Cell Dev Biol 9. https://doi.org/10.3389/fcell.2021.73431510.3389/fcell.2021.734315 ↗
2. Almeida-Porada G, Atala AJ, Porada CD (2020) Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery. Vol. 16, Mol Ther - Methods Clin Dev. Cell Press; p. 204–24. https://doi.org/10.1016/j.omtm.2020.01.00510.1016/j.omtm.2020.01.005 ↗
3. Dzobo K, Thomford NE, Senthebane DA, Shipanga H, Rowe A, Dandara C et al (2018) Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine. Stem Cells Int 2018:1–24. https://doi.org/10.1155/2018/249584810.1155/2018/2495848 ↗
4. Kim J, Eygeris Y, Gupta M, Sahay G (2021) Self-assembled mRNA vaccines. Adv Drug Deliv Rev 170:83–112. https://doi.org/10.1016/J.ADDR.2020.12.01410.1016/J.ADDR.2020.12.014 ↗
5. Hare JM, Beerman I (2019) Regenerative medicine and the biology of aging. Vol. 74, Journals of Gerontology - Series A Biological Sciences and Medical Sciences. Oxford University Press; p. 1339–40. https://doi.org/10.1093/gerona/glz13210.1093/gerona/glz132 ↗
6. Shafiee A, Atala A (2017) Tissue engineering: toward a new era of medicine. Annu Rev Med 68(1):29–40. https://doi.org/10.1146/annurev-med-102715-09233110.1146/annurev-med-102715-092331 ↗
7. Gil CJ, Li L, Hwang B, Cadena M, Theus AS, Finamore TA et al (2022) Tissue engineered drug delivery vehicles: methods to monitor and regulate the release behavior. J Control Release 349:143–155. https://doi.org/10.1016/j.jconrel.2022.04.04410.1016/j.jconrel.2022.04.044 ↗
8. Introduction to tissue engineering. In: Introduction to tissue engineering. Wiley; 2014. p. 1–39. https://doi.org/10.1002/9781118886410.ch110.1002/9781118886410.ch1 ↗
9. Li J, Wang Q, Xia G, Adilijiang N, Li Y, Hou Z et al (2023) Recent advances in targeted drug delivery strategy for enhancing oncotherapy. Pharmaceutics 15(9):2233. https://doi.org/10.3390/pharmaceutics1509223310.3390/pharmaceutics15092233 ↗
10. Bordbar-Khiabani A, Gasik M (2022) Smart hydrogels for advanced drug delivery systems. Int J Mol Sci 23(7):3665. https://doi.org/10.3390/ijms2307366510.3390/ijms23073665 ↗
11. Mansour A, Romani M, Acharya AB, Rahman B, Verron E, Badran Z (2023) Drug delivery systems in regenerative medicine: an updated review. Pharmaceutics 15(2):695. https://doi.org/10.3390/pharmaceutics1502069510.3390/pharmaceutics15020695 ↗
12. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ et al (2023) Advances in drug delivery systems, challenges and future directions. Heliyon 9(6):e17488. https://doi.org/10.1016/j.heliyon.2023.e1748810.1016/j.heliyon.2023.e17488 ↗
13. Gullotti E, Yeo Y (2009) Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol Pharm 6(4):1041–1051. https://doi.org/10.1021/mp900090z10.1021/mp900090z ↗
14. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20(2):101–124. https://doi.org/10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
15. Wang Y, Wang L, Chen G, Gong S (2017) Carboplatin‐complexed and cRGD‐Conjugated unimolecular nanoparticles for targeted ovarian cancer therapy. Macromol biosci 17(5). https://doi.org/10.1002/mabi.20160029210.1002/mabi.201600292 ↗
16. Yu H, Yang Z, Li F, Xu L, Sun Y (2020) Cell-mediated targeting drugs delivery systems. Drug Deliv 27(1):1425–1437. https://doi.org/10.1080/10717544.2020.183110310.1080/10717544.2020.1831103 ↗
17. He M, Wang Y, Chen X, Zhao Y, Lou K, Wang Y et al (2020) Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy. J Control Release 319:1–14. https://doi.org/10.1016/j.jconrel.2019.12.01510.1016/j.jconrel.2019.12.015 ↗
18. Senapati S, Mahanta AK, Kumar S, Maiti P (2018) Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther 3(1):7. https://doi.org/10.1038/s41392-017-0004-310.1038/s41392-017-0004-3 ↗
19. Aljabali AA, Obeid MA, Bashatwah RM, Serrano-Aroca Á, Mishra V, Mishra Y et al (2023) Nanomaterials and their impact on the immune system. Int J Mol Sci 24(3):2008. https://doi.org/10.3390/ijms2403200810.3390/ijms24032008 ↗
20. Hadjianfar M, Semnani D, Varshosaz J (2018) Polycaprolactone/chitosan blend nanofibers loaded by 5-fluorouracil: an approach to anticancer drug delivery system. Polym Adv Technol 29(12):2972–2981. https://doi.org/10.1002/pat.441710.1002/pat.4417 ↗
21. Kajdič S, Planinšek O, Gašperlin M, Kocbek P (2019) Electrospun nanofibers for customized drug-delivery systems. J Drug Deliv Sci Technol 51:672–681. https://doi.org/10.1016/j.jddst.2019.03.03810.1016/j.jddst.2019.03.038 ↗
22. Djayanti K, Maharjan P, Cho KH, Jeong S, Kim MS, Shin MC et al (2023) Mesoporous silica nanoparticles as a potential nanoplatform: therapeutic applications and considerations. Int J Mol Sci 24(7):6349. https://doi.org/10.3390/ijms2407634910.3390/ijms24076349 ↗
23. Niazvand F, Cheshmi A, Zand M, NasrAzadani R, Kumari B, Raza A et al (2020) An overview of the development of composites containing Mg and Zn for drug delivery. J Compos Compd 2(5):193–204. https://doi.org/10.29252/jcc.2.4.410.29252/jcc.2.4.4 ↗
24. Yang Y, Zeng W, Huang P, Zeng X, Mei L (2021) Smart materials for drug delivery and cancer therapy. View 2(2):20200042. https://doi.org/10.1002/VIW.2020004210.1002/VIW.20200042 ↗
25. Mokhtarzadeh A, Alibakhshi A, Yaghoobi H, Hashemi M, Hejazi M, Ramezani M (2016) Recent advances on biocompatible and biodegradable nanoparticles as gene carriers. Expert Opin Biol Ther 16(6):771–785. https://doi.org/10.1517/14712598.2016.116926910.1517/14712598.2016.1169269 ↗
26. Duan X, Chen H, Guo C (2022) Polymeric nanofibers for drug delivery applications: a recent review. J Mater Sci Mater Med 33(12):78. https://doi.org/10.1007/s10856-022-06700-410.1007/s10856-022-06700-4 ↗
27. Gong Z, Chen M, Ren Q, Yue X, Dai Z (2020) Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Ther 5(1):12. https://doi.org/10.1038/s41392-019-0104-310.1038/s41392-019-0104-3 ↗
28. Imran SAM, M. Hamizul MHA, Khairul Bariah AAN, Wan Kamarul Zaman WS, Nordin F (2022) Regenerative medicine therapy in Malaysia: an update. Front Bioeng Biotechnol 10. https://doi.org/10.3389/fbioe.2022.78964410.3389/fbioe.2022.789644 ↗
29. Rambhia KJ, Ma PX (2015) Controlled drug release for tissue engineering. J Control Release 219:119–128. https://doi.org/10.1016/j.jconrel.2015.08.04910.1016/j.jconrel.2015.08.049 ↗
30. Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S et al (2018) Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev 132:104–138. https://doi.org/10.1016/J.ADDR.2018.07.00210.1016/J.ADDR.2018.07.002 ↗
31. Homayun B, Lin X, Choi HJ (2019) Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Vol. 11, Pharmaceutics. MDPI AG;. https://doi.org/10.3390/pharmaceutics1103012910.3390/pharmaceutics11030129 ↗
32. Laffleur F, Keckeis V (2020) Advances in drug delivery systems: work in progress still needed? Int J Pharm 590:119912. https://doi.org/10.1016/J.IJPHARM.2020.11991210.1016/J.IJPHARM.2020.119912 ↗
33. Li C, Wang J, Wang Y, Gao H, Wei G, Huang Y et al (2019) Recent progress in drug delivery. Acta Pharm Sin B 9(6):1145–1162. https://doi.org/10.1016/J.APSB.2019.08.00310.1016/J.APSB.2019.08.003 ↗
34. Li J, Mooney DJ (2016) Designing hydrogels for controlled drug delivery. Nat Rev Mater 1(12):16071. https://doi.org/10.1038/natrevmats.2016.7110.1038/natrevmats.2016.71 ↗
35. Narayanaswamy R, Torchilin VP (2019) Hydrogels and their applications in targeted drug delivery. Molecules 24(3):603. https://doi.org/10.3390/molecules2403060310.3390/molecules24030603 ↗
36. Sun Z, Song C, Wang C, Hu Y, Wu J (2020) Hydrogel-based controlled drug delivery for cancer treatment: a review. Mol Pharm. acs.molpharmaceut.9b01020. https://doi.org/10.1021/acs.molpharmaceut.9b0102010.1021/acs.molpharmaceut.9b01020 ↗
37. McKenzie M, Betts D, Suh A, Bui K, Kim L, Cho H (2015) Hydrogel-based drug delivery systems for poorly water-soluble drugs. Molecules 20(11):20397–20408. https://doi.org/10.3390/molecules20111970510.3390/molecules201119705 ↗
38. Dreiss CA (2020) Hydrogel design strategies for drug delivery. Curr Opin Colloid Interface Sci 48:1–17. https://doi.org/10.1016/j.cocis.2020.02.00110.1016/j.cocis.2020.02.001 ↗
39. Abasalizadeh F, Moghaddam SV, Alizadeh E, Akbari E, Kashani E, Fazljou SMB et al (2020) Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting. J Biol Eng 14(1):8. https://doi.org/10.1186/s13036-020-0227-710.1186/s13036-020-0227-7 ↗
40. Kass LE, Nguyen J (2022) Nanocarrier‐hydrogel composite delivery systems for precision drug release. WIREs Nanomed Nanobiotechnol 14(2). https://doi.org/10.1002/wnan.175610.1002/wnan.1756 ↗
41. Calori IR, Braga G, de Jesus P da CC, Bi H, Tedesco AC (2020) Polymer scaffolds as drug delivery systems. Eur Polym J129:109621. https://doi.org/10.1016/j.eurpolymj.2020.10962110.1016/j.eurpolymj.2020.109621 ↗
42. Garg T, Singh O, Arora S, Murthy RSR (2012) Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29(1):1–63. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v29.i1.1010.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
43. Zhang Q, Li Y, Lin ZY (William), Wong KKY, Lin M, Yildirimer L, et al (2017) Electrospun polymeric micro/nanofibrous scaffolds for long-term drug release and their biomedical applications. Drug Discov Today 22(9):1351–66. https://doi.org/10.1016/j.drudis.2017.05.00710.1016/j.drudis.2017.05.007 ↗
44. Inglut CT, Sorrin AJ, Kuruppu T, Vig S, Cicalo J, Ahmad H et al (2020) Immunological and toxicological considerations for the design of liposomes. Nanomaterials 10(2):190. https://doi.org/10.3390/nano1002019010.3390/nano10020190 ↗
45. Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A (2016) Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol 44(1):381–391. https://doi.org/10.3109/21691401.2014.95363310.3109/21691401.2014.953633 ↗
46. He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W (2019) Adapting liposomes for oral drug delivery. Acta Pharm Sin B 9(1):36–48. https://doi.org/10.1016/j.apsb.2018.06.00510.1016/j.apsb.2018.06.005 ↗
47. Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6. https://doi.org/10.3389/fphar.2015.0028610.3389/fphar.2015.00286 ↗
48. Hadjiargyrou M, Chiu JB (2008) Enhanced composite electrospun nanofiber scaffolds for use in drug delivery. Expert Opin Drug Deliv 5(10):1093–1106. https://doi.org/10.1517/17425247.5.10.109310.1517/17425247.5.10.1093 ↗
49. Arun A, Malrautu P, Laha A, Luo H, Ramakrishna S (2021) Collagen nanoparticles in drug delivery systems and tissue engineering. Appl Sci (Switzerland) 11, MDPI;. https://doi.org/10.3390/app11231136910.3390/app112311369 ↗
50. Zhang Y, Sun T, Jiang C (2018) Biomacromolecules as carriers in drug delivery and tissue engineering. Acta Pharm Sin B 8(1):34–50. https://doi.org/10.1016/J.APSB.2017.11.00510.1016/J.APSB.2017.11.005 ↗
51. Abri Aghdam M, Bagheri R, Mosafer J, Baradaran B, Hashemzaei M, Baghbanzadeh A, et al (2019) Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release. J Control Release. Elsevier B.V. 315:1–22. https://doi.org/10.1016/j.jconrel.2019.09.01810.1016/j.jconrel.2019.09.018 ↗
52. Sponchioni M, Capasso Palmiero U, Moscatelli D (2019) Thermo-responsive polymers: applications of smart materials in drug delivery and tissue engineering. Mater Sci Eng, C 102:589–605. https://doi.org/10.1016/J.MSEC.2019.04.06910.1016/J.MSEC.2019.04.069 ↗
53. Hoang Thi TT, Pilkington EH, Nguyen DH, Lee JS, Park KD, Truong NP (2020) The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation. Polymers (Basel) 12(2):298. https://doi.org/10.3390/polym1202029810.3390/polym12020298 ↗
54. Ahsan SM, Thomas M, Reddy KK, Sooraparaju SG, Asthana A, Bhatnagar I (2018) Chitosan as biomaterial in drug delivery and tissue engineering. Int J Biol Macromol 110:97–109. https://doi.org/10.1016/J.IJBIOMAC.2017.08.14010.1016/J.IJBIOMAC.2017.08.140 ↗
55. Jacob J, Haponiuk JT, Thomas S, Gopi S (2018) Biopolymer based nanomaterials in drug delivery systems: a review. Mater Today Chem 9:43–55. https://doi.org/10.1016/J.MTCHEM.2018.05.00210.1016/J.MTCHEM.2018.05.002 ↗
56. Liu S, Qin S, He M, Zhou D, Qin Q, Wang H (2020) Current applications of poly(lactic acid) composites in tissue engineering and drug delivery. Compos B Eng 199:108238. https://doi.org/10.1016/J.COMPOSITESB.2020.10823810.1016/J.COMPOSITESB.2020.108238 ↗
57. Miao T, Wang J, Zeng Y, Liu G, Chen X (2018) Polysaccharide-based controlled release systems for therapeutics delivery and tissue engineering: from bench to bedside. Advanced Science 5(4):1700513. https://doi.org/10.1002/advs.20170051310.1002/advs.201700513 ↗
58. Vargason AM, Anselmo AC, Mitragotri S (2021) The evolution of commercial drug delivery technologies. N Biomed Eng Nat Res p. 951–67. https://doi.org/10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
59. Iqbal J, Anwar F, Afridi S (2017) Targeted drug delivery systems and their therapeutic applications in cancer and immune pathological conditions. Infect Disord Drug Targets. 17(3). https://doi.org/10.2174/187152651766617060610262310.2174/1871526517666170606102623 ↗
60. Jnaidi R, Almeida AJ, Gonçalves LM (2020) Solid lipid nanoparticles and nanostructured lipid carriers as smart drug delivery systems in the treatment of glioblastoma multiforme. Pharmaceutics. MDPI AG; 12;p. 1–19. https://doi.org/10.3390/pharmaceutics1209086010.3390/pharmaceutics12090860 ↗
61. Zhao M, van Straten D, Broekman MLD, Préat V, Schiffelers RM (2020) Nanocarrier-based drug combination therapy for glioblastoma. Theranostics. Ivyspring International Publisher; 10;p. 1355–72. https://doi.org/10.7150/thno.3814710.7150/thno.38147 ↗
62. Luna-Herrera J, Pérez-Martínez DE, Barradas-Hernández VM, Zenteno-Cuevas R (2021) Nanopartículas como transportadores de fármacos: una herramienta prometedora contra la tuberculosis. Rev Peru Med Exp Salud Publica 38(1):143–152. https://doi.org/10.17843/rpmesp.2021.381.615610.17843/rpmesp.2021.381.6156 ↗
63. Pastore MN, Kalia YN, Horstmann M, Roberts MS (2015) Transdermal patches: history, development and pharmacology. British Journal of Pharmacology. John Wiley and Sons Inc 172;p. 2179–209. https://doi.org/10.1111/bph.1305910.1111/bph.13059 ↗
64. Paula T, Bezerra W, Barros De Farias MM (2022) Fármacos e os sistemas de liberação modificada drugs and the modified release system. Europub J Health Res
65. Bezerra TPW, Bandeira ARG, de Lima SHP, de Andrade PL (2022) A nanotecnologia aplicada ao desenvolvimento de fármacos: revisão integrativa da literatura. Res, Soc Dev 11(14):e99111436115. https://doi.org/10.33448/rsd-v11i14.3611510.33448/rsd-v11i14.36115 ↗
66. Padmaa Paarakh M, Ani Jose P, Setty CM, Christoper GVP. Release kinetics-concepts and applications. 12| International Journal of Pharmacy Research & Technology |. 2019 Jan.
67. Ghorbani F, Ghalandari B, Sahranavard M, Zamanian A, Collins MN (2021) Tuning the biomimetic behavior of hybrid scaffolds for bone tissue engineering through surface modifications and drug immobilization. Mater Sci Eng, C 130:112434. https://doi.org/10.1016/J.MSEC.2021.11243410.1016/J.MSEC.2021.112434 ↗
68. Adepu S, Ramakrishna S (2021) Controlled drug delivery systems: current status and future directions. Molecules. MDPI; 26. https://doi.org/10.3390/molecules2619590510.3390/molecules26195905 ↗
69. Doberenz F, Zeng K, Willems C, Zhang K, Groth T (2020) Thermoresponsive polymers and their biomedical application in tissue engineering-a review. J Mater Chem B. Royal Soc Chem 8;p. 607–28. https://doi.org/10.1039/c9tb02052g10.1039/c9tb02052g ↗
70. Hu J, Ma PX (2011) Nano-fibrous tissue engineering scaffolds capable of growth factor delivery. Pharm Res 28(6):1273–1281. https://doi.org/10.1007/s11095-011-0367-z10.1007/s11095-011-0367-z ↗
71. Adepu S, Ramakrishna S (2021) Controlled drug delivery systems: current status and future directions. Molecules 26(19):5905. https://doi.org/10.3390/molecules2619590510.3390/molecules26195905 ↗
72. Pishnamazi M, Hafizi H, Shirazian S, Culebras M, Walker GM, Collins MN (2019) Design of controlled release system for paracetamol based on modified lignin. Polymers (Basel) 11(6). https://doi.org/10.3390/POLYM1106105910.3390/POLYM11061059 ↗
73. Tran TTD, Tran PHL (2019) Controlled release film forming systems in drug delivery: the potential for efficient drug delivery. Pharmaceutics. MDPI AG; 11. https://doi.org/10.3390/pharmaceutics1106029010.3390/pharmaceutics11060290 ↗
74. Cristina Teixeira Silva I, Raul Tavares J, Martinez Lyra A (2022) Micropartículas de liberação modificada contendo cetoprofeno. Modified release microparticles containing ketoprofEN. Visão Acadêmica 23(1). https://doi.org/10.5380/acd.v23i1.7510710.5380/acd.v23i1.75107 ↗
75. Yao Q, Liu Y, Selvaratnam B, Koodali RT, Sun H (2018) Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering. J Control Release 279:69–78. https://doi.org/10.1016/J.JCONREL.2018.04.01110.1016/J.JCONREL.2018.04.011 ↗
76. Chen S, Shi Y, Luo Y, Ma J (2019) Layer-by-layer coated porous 3D printed hydroxyapatite composite scaffolds for controlled drug delivery. Colloids Surf B Biointerfaces 179:121–127. https://doi.org/10.1016/J.COLSURFB.2019.03.06310.1016/J.COLSURFB.2019.03.063 ↗
77. Glassman PM, Myerson JW, Ferguson LT, Kiseleva RY, Shuvaev VV, Brenner JS et al (2020) Targeting drug delivery in the vascular system: focus on endothelium. Adv Drug Deliv Rev 157:96–117. https://doi.org/10.1016/j.addr.2020.06.01310.1016/j.addr.2020.06.013 ↗
78. Huang Y, Cao L, Parakhonskiy BV, Skirtach AG (2022) Hard, soft, and hard-and-soft drug delivery carriers based on CaCO3 and alginate biomaterials: synthesis, properties, pharmaceutical applications. Pharmaceutics 14(5):909. https://doi.org/10.3390/pharmaceutics1405090910.3390/pharmaceutics14050909 ↗
79. Bordon G, Berenbaum F, Distler O, Luciani P (2023) Harnessing the multifunctionality of lipid-based drug delivery systems for the local treatment of osteoarthritis. Biomed Pharmacother 168:115819. https://doi.org/10.1016/j.biopha.2023.11581910.1016/j.biopha.2023.115819 ↗
80. Cui M, Pan H, Fang D, Sun H, Pan W (2022) 3D printed personalized amikacin sulfate local drug delivery system for bone defect therapy. J Drug Deliv Sci Technol 70:103208. https://doi.org/10.1016/j.jddst.2022.10320810.1016/j.jddst.2022.103208 ↗
81. Yourdkhani A, Esfandyari-Manesh M, Ranjbaran P, Dinarvand R (2024) Local multi-drug delivery and osteogenesis in bone metastasis of prostate cancer by a core-shell 3D printed scaffold. J Drug Deliv Sci Technol 92:105345. https://doi.org/10.1016/j.jddst.2024.10534510.1016/j.jddst.2024.105345 ↗
82. Ganesh VS, Venkatesh KV, Sihivahanan D, Yadalam PK, Shrivastava D, Srivastava KC (2024) Effect of microbubble as local drug delivery system in endodontic management - an in-vitro study. Saudi Dent J 36(6):863–867. https://doi.org/10.1016/j.sdentj.2024.03.01010.1016/j.sdentj.2024.03.010 ↗
83. Pulingam T, Foroozandeh P, Chuah J-A, Sudesh K (2022) Exploring various techniques for the chemical and biological synthesis of polymeric nanoparticles. Nanomaterials 12(3):576. https://doi.org/10.3390/nano1203057610.3390/nano12030576 ↗
84. Zhang Q, Zhou J, Zhi P, Liu L, Liu C, Fang A et al (2023) 3D printing method for bone tissue engineering scaffold. Med Nov Technol Devices 17:100205. https://doi.org/10.1016/j.medntd.2022.10020510.1016/j.medntd.2022.100205 ↗
85. Singh B, Kim K, Park M-H (2021) On-demand drug delivery systems using nanofibers. Nanomaterials 11(12):3411. https://doi.org/10.3390/nano1112341110.3390/nano11123411 ↗
86. Al-Sakkaf MK, Onaizi SA (2024) Effects of emulsification factors on the characteristics of crude oil emulsions stabilized by chemical and biosurfactants: a review. Fuel 361:130604. https://doi.org/10.1016/j.fuel.2023.13060410.1016/j.fuel.2023.130604 ↗
87. Jhaveri J, Raichura Z, Khan T, Momin M, Omri A (2021) Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics. Molecules 26(2):272. https://doi.org/10.3390/molecules2602027210.3390/molecules26020272 ↗
88. Goole J, Amighi K (2016) 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm 499(1–2):376–394. https://doi.org/10.1016/J.IJPHARM.2015.12.07110.1016/J.IJPHARM.2015.12.071 ↗
89. Alhnan MA, Okwuosa TC, Sadia M, Wan K-W, Ahmed W, Arafat B (2016) Emergence of 3D printed dosage forms: opportunities and challenges. Pharm Res 33(8):1817–1832. https://doi.org/10.1007/s11095-016-1933-110.1007/s11095-016-1933-1 ↗
90. Aoki K, Saito N (2020) Biodegradable polymers as drug delivery systems for bone regeneration. Pharmaceutics. MDPI AG;12. https://doi.org/10.3390/pharmaceutics1202009510.3390/pharmaceutics12020095 ↗
91. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. BioMed Central Ltd; 16. https://doi.org/10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
92. Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh FA (2019) Lipid-based nanoparticles for drug delivery systems. Characterization and Biology of Nanomaterials for Drug Delivery. https://doi.org/10.1016/C2017-0-00272-010.1016/C2017-0-00272-0 ↗
93. Zahin N, Anwar R, Tewari D, Kabir MT, Sajid A, Mathew B et al (2020) Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery. Environ Sci Pollut Res 27(16):19151–19168. https://doi.org/10.1007/s11356-019-05211-010.1007/s11356-019-05211-0 ↗
94. Gordillo-Galeano A, Mora-Huertas CE (2018) Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release. Eur J Pharm Biopharm 133:285–308. https://doi.org/10.1016/J.EJPB.2018.10.01710.1016/J.EJPB.2018.10.017 ↗
95. Sobreiro-Almeida R, Quinteira R, Neves NM (2021) Renal regeneration: the role of extracellular matrix and current ECM-based tissue engineered strategies. Adv Healthc Mater 10(14):2100160. https://doi.org/10.1002/adhm.20210016010.1002/adhm.202100160 ↗
96. Krishani M, Shin WY, Suhaimi H, Sambudi NS (2023) Development of scaffolds from bio-based natural materials for tissue regeneration applications: a review. Gels 9(2):100. https://doi.org/10.3390/gels902010010.3390/gels9020100 ↗
97. Anand D, Schumacher D, Søgaard-Andersen L (2020) SMC and the bactofilin/PadC scaffold have distinct yet redundant functions in chromosome segregation and organization in Myxococcus xanthus. Mol Microbiol 114(5):839–856. https://doi.org/10.1111/mmi.1458310.1111/mmi.14583 ↗
98. Khalil HPSA, Jummaat F, Yahya EB, Olaiya NG, Adnan AS, Abdat M et al (2020) A review on micro- to nanocellulose biopolymer scaffold forming for tissue engineering applications. Polymers (Basel) 12(9):2043. https://doi.org/10.3390/polym1209204310.3390/polym12092043 ↗
99. Al Ragib A, Chakma R, Dewan K, Islam T, Kormoker T, Idris AM (2022) Current advanced drug delivery systems: challenges and potentialities. J Drug Deliv Sci Technol 76:103727. https://doi.org/10.1016/j.jddst.2022.10372710.1016/j.jddst.2022.103727 ↗
100. Abdelaziz AG, Nageh H, Abdo SM, Abdalla MS, Amer AA, Abdal-hay A et al (2023) A review of 3D polymeric scaffolds for bone tissue engineering: principles, fabrication techniques, immunomodulatory roles, and challenges. Bioengineering 10(2):204. https://doi.org/10.3390/bioengineering1002020410.3390/bioengineering10020204 ↗